<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">rpcardio</journal-id><journal-title-group><journal-title xml:lang="en">Rational Pharmacotherapy in Cardiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Рациональная Фармакотерапия в Кардиологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1819-6446</issn><issn pub-type="epub">2225-3653</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">rpcardio-1190</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group></article-categories><title-group><article-title>Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease</article-title><trans-title-group xml:lang="ru"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Leonova</surname><given-names>E. I</given-names></name><name name-style="western" xml:lang="en"><surname>Leonova</surname><given-names>E. I.</given-names></name></name-alternatives><email xlink:type="simple">zei86@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Shechyan</surname><given-names>G. G.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Zadionchenko</surname><given-names>V. S.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Adasheva</surname><given-names>T. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Deev</surname><given-names>A. D.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Fedorova</surname><given-names>I. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="en" id="aff-1"><institution>Moscow State University of Medicine and Dentistry named after A.I. Evdokimov. Delegatskaya ul. 20-1, Moscow, 127473 Russia</institution><country>Russian Federation</country></aff><aff xml:lang="en" id="aff-2"><institution>State Research Center for Preventive Medicine. Petroverigsky per.10, Moscow,101990 Russia</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>06</day><month>07</month><year>2021</year></pub-date><volume>12</volume><issue>6</issue><fpage>26</fpage><lpage>30</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Leonova E.I., Shechyan G.G., Zadionchenko V.S., Adasheva T.V., Deev A.D., Fedorova I.V., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Leonova E.I., Shechyan G.G., Zadionchenko V.S., Adasheva T.V., Deev A.D., Fedorova I.V.</copyright-holder><copyright-holder xml:lang="en">Leonova E.I., Shechyan G.G., Zadionchenko V.S., Adasheva T.V., Deev A.D., Fedorova I.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpcardio.online/jour/article/view/1190">https://www.rpcardio.online/jour/article/view/1190</self-uri><abstract><sec><title>Aim</title><p>Aim. To study the relationships between clinical and functional features of chronic obstructive pulmonary disease (COPD) and status of cardiovascular system with focus on identifying factors associated with the atrial fibrillation (AF) in patients with COPD.</p></sec><sec><title>Material and methods</title><p>Material and methods. Patients (n=94) with COPD out of exacerbation and airways obstruction of 2-4 degree (GOLD 2013) were examined. The spirometry, daily pulse oximetry, 24-hour ECG and blood pressure monitoring with vascular wall stiffness estimation, echocardiography were performed. Levels of high-sensitivity C-reactive protein (CRP) were also assessed.</p></sec><sec><title>Results</title><p>Results. AF paroxysms were found in 46 patients, including newly diagnosed ones in 22 patients. According to the results of multiple correlation analysis, the frequency of AF paroxysms correlated with forced expiratory volume in 1 sec (FEV1) (R=-0.348; p=0.013), minimum oxygen saturation of the blood (min%SpO2) (R=-0.356; p=0.011), CRP level (R=0.442; p=0.001), the sizes of both atria (p&lt;0.001), isovolumic relaxation time (IVRT) of left ventricle (LV) (R=0.350; p=0.022), the right ventricle (RV) size (R=0.478; p&lt;0.001), systolic blood pressure level in the pulmonary artery (PASP) (р&lt;0.001), vascular stiffness - pulse wave velocity in aorta (PWao) (p=0.001). The influence of FEV1 on the left atrium volume index (χ2=7.0; p=0.008) and IVRT LV (χ2=7.9; p=0.005) was revealed. Correlations between min%SpO2 and IVRT and PWao were observed.</p></sec><sec><title>Conclusion</title><p>Conclusion. Severe bronchial obstruction, hypoxemia, systemic inflammation with increase in vascular stiffness (PWao) and myocardium remodeling (increase in the sizes of both atria, PASP, RV size and diastolic dysfunction of LV) are the factors that associated with the occurrence of AF in patients with COPD.</p></sec></abstract><kwd-group xml:lang="en"><kwd>atrial fibrillation</kwd><kwd>chronic obstructive pulmonary disease</kwd><kwd>myocardial remodeling</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Losano R., Naghavi M., Foreman K. Оn behalf of the research team global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Diseases Study. Lancet 2012;380:2095-118.</mixed-citation><mixed-citation xml:lang="en">Losano R., Naghavi M., Foreman K. Оn behalf of the research team global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Diseases Study. Lancet 2012;380:2095-118.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Sin D., Anthonisen N., Soriano J., Agusti F. Mortality in COPD: Role of comorbidities. Eur Resp J 2006;28:1245-57.</mixed-citation><mixed-citation xml:lang="en">Sin D., Anthonisen N., Soriano J., Agusti F. Mortality in COPD: Role of comorbidities. Eur Resp J 2006;28:1245-57.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Shugushev H. H., Gurieva M. V., Vasilenko V. M. Supraventricular arrhythmia and high resolution ECG in patients with chronic obstructive pulmonary disease on the background of broncholytic therapy. Rossiyskiy Kardiologicheskiy Zhurnal 2010; 6 (86):40-4. In Russian (Шугушев Х. Х., Гурижева М. В., Василенко В. М. Наджелудочковые аритмии и ЭКГ высокого разрешения у больных хронической обструктивной болезнью легких на фоне бронхолитической терапии. Российский Кардиологический Журнал 2010; 6 (86):40-4).</mixed-citation><mixed-citation xml:lang="en">Shugushev H. H., Gurieva M. V., Vasilenko V. M. Supraventricular arrhythmia and high resolution ECG in patients with chronic obstructive pulmonary disease on the background of broncholytic therapy. Rossiyskiy Kardiologicheskiy Zhurnal 2010; 6 (86):40-4. In Russian (Шугушев Х. Х., Гурижева М. В., Василенко В. М. Наджелудочковые аритмии и ЭКГ высокого разрешения у больных хронической обструктивной болезнью легких на фоне бронхолитической терапии. Российский Кардиологический Журнал 2010; 6 (86):40-4).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Shibata Y, Watanabe T, Osaka D, et al. Impairment of Pulmonary Function is an Independent Risk Factor for Atrial Fibrillation: The Takahata Study. Int J Med Sci 2011;8(7): 514-22.</mixed-citation><mixed-citation xml:lang="en">Shibata Y, Watanabe T, Osaka D, et al. Impairment of Pulmonary Function is an Independent Risk Factor for Atrial Fibrillation: The Takahata Study. Int J Med Sci 2011;8(7): 514-22.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Tamagawa E., van Eeden S. F. Impaired lung function and risk for stroke: role of the systemic inflammation response? Chest 2006; 130(6): 1631-3.</mixed-citation><mixed-citation xml:lang="en">Tamagawa E., van Eeden S. F. Impaired lung function and risk for stroke: role of the systemic inflammation response? Chest 2006; 130(6): 1631-3.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Feary J. R., Rodrigues L. C., Smith C. J., et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010; 11: 956-62.</mixed-citation><mixed-citation xml:lang="en">Feary J. R., Rodrigues L. C., Smith C. J., et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010; 11: 956-62.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kang H, Bae BS, Kim JH. et al. The relationship between chronic atrial fibrillation and reduced pulmonary function in cases of preserved left ventricular systolic function. Korean Circ J 2009;39: 372-7.</mixed-citation><mixed-citation xml:lang="en">Kang H, Bae BS, Kim JH. et al. The relationship between chronic atrial fibrillation and reduced pulmonary function in cases of preserved left ventricular systolic function. Korean Circ J 2009;39: 372-7.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339: 659-66.</mixed-citation><mixed-citation xml:lang="en">Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339: 659-66.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Melnichenko O.V., Nekrasov A.A., Kuznetsov A.N. Factors Associated with the Development of Atrial Fibrillation in Chronic Obstructive Pulmonary Disease. IJBM 2011; 1(2): 71-3.</mixed-citation><mixed-citation xml:lang="en">Melnichenko O.V., Nekrasov A.A., Kuznetsov A.N. Factors Associated with the Development of Atrial Fibrillation in Chronic Obstructive Pulmonary Disease. IJBM 2011; 1(2): 71-3.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Maclay J.D., Mc Alister D.A., William M.N. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 2007;12 (5): 634-41.</mixed-citation><mixed-citation xml:lang="en">Maclay J.D., Mc Alister D.A., William M.N. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 2007;12 (5): 634-41.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Y.S., Feng YC, Zhang J. Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients. Clin Interv Aging 2014;10:81-7.</mixed-citation><mixed-citation xml:lang="en">Huang Y.S., Feng YC, Zhang J. Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients. Clin Interv Aging 2014;10:81-7.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Caram L.M., Ferrari R, Naves CR. Association between left ventricular diastolic dysfunction and severity of chronic obstructive pulmonary disease. Clinics (Sao Paulo) 2013;6: 772-6.</mixed-citation><mixed-citation xml:lang="en">Caram L.M., Ferrari R, Naves CR. Association between left ventricular diastolic dysfunction and severity of chronic obstructive pulmonary disease. Clinics (Sao Paulo) 2013;6: 772-6.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated 2016). Available at: http://www.goldcopd.org/uploads/users/files/Watermarked-Global%20Strategy%202016(1).pdf. Checked by 09.02.2016.</mixed-citation><mixed-citation xml:lang="en">Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated 2016). Available at: http://www.goldcopd.org/uploads/users/files/Watermarked-Global%20Strategy%202016(1).pdf. Checked by 09.02.2016.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Andersson T., Magnuson A, Bryngelsson IL. et al. All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study. Eur Heart J 2013;34(14):1061-7.</mixed-citation><mixed-citation xml:lang="en">Andersson T., Magnuson A, Bryngelsson IL. et al. All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study. Eur Heart J 2013;34(14):1061-7.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Geltser B. I., Brodskaya T. A., Nevzorova V. A. Evaluation of arterial stiffness in patients with chronic obstructive pulmonary disease. Puimonologiia 2008; 1: 45-50. In Russian (Гельцер Б.И., Бродская Т.А., Невзорова В.А. Оценка артериальной ригидности у больных хронической обструктивной болезнью легких. Пульмонология 2008; 1: 45-50).</mixed-citation><mixed-citation xml:lang="en">Geltser B. I., Brodskaya T. A., Nevzorova V. A. Evaluation of arterial stiffness in patients with chronic obstructive pulmonary disease. Puimonologiia 2008; 1: 45-50. In Russian (Гельцер Б.И., Бродская Т.А., Невзорова В.А. Оценка артериальной ригидности у больных хронической обструктивной болезнью легких. Пульмонология 2008; 1: 45-50).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Funk GC, Lang I, Schenk P. Left Ventricular Diastolic Dysfunction in Patients With COPD in the Presence and Absence of Elevated Pulmonary Arterial Pressure. Chest 2008; 133 (6): 1354-9.</mixed-citation><mixed-citation xml:lang="en">Funk GC, Lang I, Schenk P. Left Ventricular Diastolic Dysfunction in Patients With COPD in the Presence and Absence of Elevated Pulmonary Arterial Pressure. Chest 2008; 133 (6): 1354-9.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
